Evolution of the hypervariable region of hepatitis C virus in patients with chronic hepatitis C who were treated with interferon.

被引：0
|
作者：
Hino, K [1 ]
Yamaguchi, Y [1 ]
Fujiwara, D [1 ]
Katoh, Y [1 ]
Korenaga, M [1 ]
Okuda, M [1 ]
Okita, K [1 ]
机构：
[1] Yamaguchi Univ, Sch Med, Ube, Yamaguchi 755, Japan
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1778
引用
收藏
页码：605A / 605A
页数：1
相关论文
共 50 条
  • [21] Evolution of viral quasispecies in interferon-treated patients with chronic hepatitis C virus infection
    Hassoba, HM
    Bzowej, N
    Berenguer, M
    Kim, M
    Zhou, S
    Phung, Y
    Grant, R
    Pessoa, MG
    Wright, TL
    JOURNAL OF HEPATOLOGY, 1999, 31 (04) : 618 - 627
  • [22] Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: Relationship to antibody response against hypervariable region genome
    Aiyama, T
    Yoshioka, K
    Okumura, A
    Takayanagi, M
    Iwata, K
    Ishikawa, T
    Kakumu, S
    HEPATOLOGY, 1996, 24 (06) : 1346 - 1350
  • [23] Changes in hypervariable region 1 after interferon therapy of patients with chronic hepatitis C.
    Tanaka, M
    Nishiguchi, S
    Enomoto, M
    Kuroooka, H
    Minamitani, S
    Fukuda, K
    Tamori, A
    Habu, D
    Takeda, T
    Shiomi, S
    Otani, S
    Todo, N
    HEPATOLOGY, 2000, 32 (04) : 355A - 355A
  • [24] Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C (CHC) with pegylated interferon and ribavirin
    Gallegos, JF
    Rakela, J
    Rosati, MJ
    Vargas, H
    Balan, V
    HEPATOLOGY, 2005, 42 (04) : 565A - 566A
  • [25] Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa
    Tanaka, E
    Kiyosawa, K
    Matsumoto, A
    Kashiwakuma, T
    Hasegawa, A
    Mori, H
    Yanagihara, O
    Ohta, Y
    HEPATOLOGY, 1996, 23 (06) : 1330 - 1333
  • [26] Evolution of genetic heterogeneity of the hypervariable region 1 in patients with chronic hepatitis C non responders to interferon therapy.
    Thelu, MA
    Baud, M
    Leroy, V
    Seigneurin, JM
    Zarski, JP
    HEPATOLOGY, 1997, 26 (04) : 328 - 328
  • [27] Hepatitis G virus infection in patients with hepatitis C treated with interferon
    Salas, E
    GonzalezVilchez, J
    Rebollo, J
    Pinar, A
    Martin, J
    Jimenez, M
    Herrerias, JM
    HEPATOLOGY, 1996, 24 (04) : 1784 - 1784
  • [28] Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alfa interferon.
    Herrera, J
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [29] Efficacy of Rebetron (interferon and ribavirin) combination therapy in the treatment of patients with chronic hepatitis C not previously treated with interferon.
    Nelson, JB
    HEPATOLOGY, 2000, 32 (04) : 553A - 553A
  • [30] Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C
    Radkowski, M
    Jablonska, J
    Wilkinson, J
    Colby, TV
    Walewska-Zielecka, B
    Adair, DM
    Rakela, J
    Laskus, T
    HEPATOLOGY, 2004, 40 (04) : 180A - 180A
12345